Member Info for Jacobjohn7

Fill your boots

Miley... get with the program... nice to see news replicated over socials.

But thanks

We're all on the one pro-polarean side now.

Happy to have got in at 1.23 and 1.25

And good luck all

Happy valentines day, don't go crazy on the champers

Https://www.linkedin.com/posts/polarean-inc-_innovation-xenonmri-pulmonaryimaging-activity-7295884156440379393-Qw9t?utm_source=share&utm_medium=member_android

Https://www.linkedin.com/posts/alan-huang-phd_xenonmri-xenonmri-sbrt-ugcPost-7295434253515845632-Hxqt?utm_source=share&utm_medium=member_android

So much going on here.

The sales guys will be bringing the deals in.

Taiwan deal soon

6-12 year old fda expansion imminent

Second Chinese patent incoming

Chinese distribution partner incoming

Duke and iowa confirmation of deals for clinical upgrades on the way.

Simonmed 1 site, with several potential short term.

100s long term

Fantastic opportunity

Transformational what has occurred here recently

All looking rosey.

Next news will be immense reaction here. Had plenty of confirmation recently, but give us more soon, and we will all be very happy here.

Gla

Https://www.linkedin.com/posts/polarean-inc-_mri-pulmonaryimaging-lunghealth-activity-7294739548708712451-d3po?utm_source=share&utm_medium=member_android

Good summary of vox interview from advfn.

Just re watched the enlightening video below.

Key take outs.

- Another patent in china being actioned.

- will update the market on distribution partner In China.

- sourcing quality partners, taking their time to get the best (seems have numerous suitors)

- Taiwan sales potential pre regulatory on a trial basis.

- numerous interest from institutions Taiwan already.

Polarean CEO, Christopher Von Jako on Recent Milestones and Future Plans - Vox Markets https://search.app/JUJyhXyqkXoKbpy48

Some rocket fuel in the pipeline there.

Stay primed and ready for news anytime. Some will create such a turnaround in sp here.

Figures for full year hopefully on course to beat or be top end of expectations.

Not sure a Taiwan partner would initially pay for the privilege initially or vice versa. It's kind of selling the rights to a market so maybe?

Also simonmed would like to know if any payments for arizona within those figures.

The Asia side of business now has de risked and widened the market and also demonstrated the how busy in the background they have been during the 6 months without much newsflow.

The 6-12 year old fda expansion is due literally any time now.

Seem to remember the other fda dropped us time, so mid aft uk.

Gla.

Will close the gap. And more.

Once medical budgets are regenerated my belief and from broker notes and the company we will get.

Duke x2 systems at least

Iowa maybe multiples again.

Hannover has been involved strongly in research with polarean and could be added to the short term list.

A deal in China will make our years here. Then we have Taiwan in early may.

I suspect we may see a partner company selling into Japan.

Maybe they've been very proactive and gone for more asia.

Sky seems the limit after the recent background proactivity displayed

The gap fill initially would be excellent, I feel we need another revenue deal for that.

I did say another deal would test the 2p if we can put arizona in that bracket.

But selling into Taiwan from start may is fantastic. People are finally getting it. As spunken says 1.65 likely with buying pressure

Looks that way

Regulatory approval for Taiwan late April. Early may. Assuming its the first letter they sent!

Which it should be.

Then my friends we have another region to expand into

The 9dma has crossed the 20mda... sign to buy for people who follow technicals.

And we finished over the 100dma another.

The news and further news is the main thing, but these technicals being broken are good and set for more recovery.

Way the company is shaping at the moment, a real transformation in 2025 who knows we may get more good news soon.

The negative barren period is over. Enjoy the rise. Long may it continue.

The time franes with an fda approved device will see us selling into Taiwan second half 2025.

Nice. Seems we have some waiting in line already .

Does Taiwan FDA accept US FDA approval as reference for medical device and diagnostics registration?

Yes, the Taiwan Food and Drug Administration (TFDA) does consider US FDA approval during the medical device registration process. For Class II medical devices that have approval in the US, manufacturers can usually use existing documentation in place of the preclinical test, quality control procedure, and test reports1. However, it’s important to note that this does not replace the need for TFDA approval. All imported medical devices must still obtain a registration certificate from the TFDA.

What are the timelines for review and approval of medical devices in Taiwan?

The review and approval timelines for medical devices in Taiwan vary depending on the class of the device:

Class I Medical Devices: The Taiwan Food and Drug Administration (TFDA) takes about 90 working days for the review of Class I medical device applications.

Class II and III Medical Devices: The review process for Class II and III medical devices takes about 180 working days.

Please note that these timelines are approximate and can vary based on the specifics of the device and the completeness of the application.

I don't need to filter anyone i have a stronger mind than that. I'm confident enough and happy enough for the filter to be used for me. Your loss... wouldn't it be great to use it in real life... now wouldn't that be fantastic..

We don't need ai to tell us the risks and potentiap reward, and no mention of our emerging Asian markets.

Polx will need cash early 2026. But hopefully by then we will be at a higher mark.

An acquisition occurs around the 10p mark id happily accept.

For the benefit of tool shed Mike.

He has investment in his name, but that's just letters he does not understand.

Prior to the raft of exciting news the cash runway was being eroded for over 6 months without any additional commercial traction.

The recent news gives optimism and extra regions de risk a bit and proves to me that they have some dynamism, you look at the Whole picture before investing. My previous stance wss I didn't see anything occurring for a while ... over 7 months I was right we had zero , I took my investment out, and I look at the complexion of the company now and re evaluate and buy more at very cheap , meanwhile bland frustrated Mike watches his investment go down.

The more astute has to evaluate the state of play, we still need some tonic for that cash runway but I am now optimistic that deals will occur and we get to the stage where those medical budgets are regenerated for current year, thus allowing Duke and i believe iowa to purchase full clinical systems.

But all Mike can think about is getting triggered by his betters. Get a life man

Maybe a mention of blinkered Mike rhe prick of the board

Good sign and the news and momentum.

Think we should have a decent run, need revenue news to test 2p though.

It's nice to finally get traction and happy was able to buy nearly 2m in low mid 1.2s.

The benefits of not being a blinkered manic mike

Steady as she goes

Goldman Sachs cuts ITM Power price target to 32 (34) pence - 'sell'